CEL-SCI Corporation Logo

CEL-SCI Corporation

CVM

(1.0)
Stock Price

0,56 USD

-119.03% ROA

-233.88% ROE

-1.99x PER

Market Cap.

64.567.860,00 USD

143.19% DER

0% Yield

0% NPM

CEL-SCI Corporation Stock Analysis

CEL-SCI Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

CEL-SCI Corporation Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a reasonable amount of debt compared to its ownership (95%), suggesting a balanced financial position and a moderate level of risk.

2 Revenue Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

3 Net Profit Growth

With continuous net profit growth in the past three years, this company demonstrates a strong financial performance, making it an enticing investment opportunity.

4 Graham Number

The company's Graham number suggests that its stock price is underestimated, implying that it may present a compelling investment opportunity.

5 ROE

The stock's ROE indicates a negative return (-145.93%) on shareholders' equity, suggesting poor financial performance.

6 ROA

The stock's ROA (-106.36%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

7 PBV

The stock's elevated P/BV ratio (6.52x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

8 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

CEL-SCI Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

CEL-SCI Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

CEL-SCI Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

CEL-SCI Corporation Revenue
Year Revenue Growth
1986 100.000
1987 100.000 0%
1988 100.000 0%
1989 100.000 0%
1990 100.000 0%
1991 100.000 0%
1992 400.000 75%
1993 1.000.000 60%
1994 100.000 -900%
1995 100.000 0%
1996 300.000 66.67%
1997 400.000 25%
1998 100.000 -300%
1999 400.000 75%
2000 402.011 0.5%
2001 376.221 -6.86%
2002 384.939 2.26%
2003 318.304 -20.93%
2004 325.479 2.2%
2005 269.925 -20.58%
2006 125.457 -115.15%
2007 57.043 -119.93%
2008 5.065 -1026.22%
2009 80.093 93.68%
2010 153.300 47.75%
2011 956.154 83.97%
2012 254.610 -275.54%
2013 160 -160032.08%
2014 264 39.77%
2015 657.377 99.96%
2016 285.055 -130.61%
2017 69.020 -313%
2018 476.556 85.52%
2019 462.754 -2.98%
2020 558.664 17.17%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

CEL-SCI Corporation Research and Development Expenses
Year Research and Development Expenses Growth
1986 0
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 2.900.000 100%
1995 1.800.000 -61.11%
1996 3.500.000 48.57%
1997 6.000.000 41.67%
1998 3.800.000 -57.89%
1999 4.500.000 15.56%
2000 4.978.714 9.62%
2001 7.762.213 35.86%
2002 4.699.909 -65.16%
2003 1.915.501 -145.36%
2004 1.941.630 1.35%
2005 2.229.729 12.92%
2006 1.896.976 -17.54%
2007 2.528.528 24.98%
2008 4.101.563 38.35%
2009 6.011.750 31.77%
2010 11.911.626 49.53%
2011 11.745.629 -1.41%
2012 10.368.695 -13.28%
2013 12.681.049 18.23%
2014 17.000.145 25.41%
2015 20.949.208 18.85%
2016 19.351.779 -8.25%
2017 15.606.985 -23.99%
2018 9.400.306 -66.03%
2019 12.659.287 25.74%
2020 17.840.290 29.04%
2021 23.108.897 22.8%
2022 25.355.346 8.86%
2023 22.471.496 -12.83%
2024 18.812.640 -19.45%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

CEL-SCI Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
1986 1.000.000
1987 800.000 -25%
1988 1.400.000 42.86%
1989 900.000 -55.56%
1990 700.000 -28.57%
1991 800.000 12.5%
1992 1.300.000 38.46%
1993 1.700.000 23.53%
1994 1.600.000 -6.25%
1995 1.700.000 5.88%
1996 2.900.000 41.38%
1997 2.300.000 -26.09%
1998 3.100.000 25.81%
1999 3.200.000 3.13%
2000 3.721.240 14.01%
2001 3.432.437 -8.41%
2002 1.754.332 -95.65%
2003 2.287.019 23.29%
2004 2.310.279 1.01%
2005 1.930.543 -19.67%
2006 3.406.775 43.33%
2007 6.704.538 49.19%
2008 5.200.735 -28.92%
2009 5.671.595 8.3%
2010 6.285.810 9.77%
2011 6.664.883 5.69%
2012 6.595.287 -1.06%
2013 6.982.686 5.55%
2014 10.606.248 34.16%
2015 13.797.964 23.13%
2016 6.486.501 -112.72%
2017 5.800.348 -11.83%
2018 7.848.496 26.1%
2019 7.998.573 1.88%
2020 11.703.429 31.66%
2021 13.085.232 10.56%
2022 10.707.447 -22.21%
2023 9.004.578 -18.91%
2024 7.868.300 -14.44%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

CEL-SCI Corporation EBITDA
Year EBITDA Growth
1986 -2.300.000
1987 -1.500.000 -53.33%
1988 -1.200.000 -25%
1989 -700.000 -71.43%
1990 -400.000 -75%
1991 -500.000 20%
1992 -1.100.000 54.55%
1993 -1.700.000 35.29%
1994 -4.800.000 64.58%
1995 -3.300.000 -45.45%
1996 -6.200.000 46.77%
1997 -8.000.000 22.5%
1998 -7.600.000 -5.26%
1999 -7.400.000 -2.7%
2000 -8.338.483 11.25%
2001 -11.112.300 24.96%
2002 -3.990.023 -178.5%
2003 -1.647.505 -142.19%
2004 -3.812.153 56.78%
2005 -4.878.847 21.86%
2006 -2.608.179 -87.06%
2007 -8.863.784 70.57%
2008 -10.847.520 18.29%
2009 16.888.398 164.23%
2010 -46.887.908 136.02%
2011 -9.886.506 -374.26%
2012 -16.593.311 40.42%
2013 -19.387.066 14.41%
2014 -27.219.506 28.78%
2015 -33.979.251 19.89%
2016 -39.416.708 13.79%
2017 -31.712.613 -24.29%
2018 -7.478.554 -324.05%
2019 -18.800.974 60.22%
2020 -25.898.959 27.41%
2021 -32.285.855 19.78%
2022 -32.157.521 -0.4%
2023 -27.560.553 -16.68%
2024 -22.748.120 -21.16%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

CEL-SCI Corporation Gross Profit
Year Gross Profit Growth
1986 -1.300.000
1987 -800.000 -62.5%
1988 100.000 900%
1989 100.000 0%
1990 100.000 0%
1991 0 0%
1992 -100.000 100%
1993 -300.000 66.67%
1994 100.000 400%
1995 100.000 0%
1996 300.000 66.67%
1997 400.000 25%
1998 100.000 -300%
1999 400.000 75%
2000 402.011 0.5%
2001 376.221 -6.86%
2002 384.939 2.26%
2003 318.304 -20.93%
2004 325.479 2.2%
2005 269.925 -20.58%
2006 125.457 -115.15%
2007 57.043 -119.93%
2008 5.065 -1026.22%
2009 80.093 93.68%
2010 153.300 47.75%
2011 956.154 83.97%
2012 244.242 -291.48%
2013 -12.521 2050.66%
2014 -15.002 16.53%
2015 638.186 102.35%
2016 267.610 -138.48%
2017 -563.980 147.45%
2018 465.642 221.12%
2019 450.095 -3.45%
2020 540.824 16.78%
2021 -499.000 208.38%
2022 -3.883.386 87.15%
2023 -3.958.334 1.89%
2024 -3.932.832 -0.65%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

CEL-SCI Corporation Net Profit
Year Net Profit Growth
1986 -2.900.000
1987 -1.700.000 -70.59%
1988 -1.300.000 -30.77%
1989 -1.100.000 -18.18%
1990 -900.000 -22.22%
1991 -1.200.000 25%
1992 -1.700.000 29.41%
1993 -2.400.000 29.17%
1994 -4.400.000 45.45%
1995 -3.900.000 -12.82%
1996 -6.300.000 38.1%
1997 -8.200.000 23.17%
1998 -6.400.000 -28.13%
1999 -7.500.000 14.67%
2000 -8.478.397 11.54%
2001 -10.733.679 21.01%
2002 -8.342.244 -28.67%
2003 -6.371.498 -30.93%
2004 -4.199.722 -51.71%
2005 -3.039.607 -38.17%
2006 -7.939.210 61.71%
2007 -9.629.657 17.55%
2008 -7.703.415 -25.01%
2009 -40.910.030 81.17%
2010 10.483.429 490.24%
2011 -25.712.343 140.77%
2012 -15.477.310 -66.13%
2013 -9.170.947 -68.76%
2014 -27.366.265 66.49%
2015 -34.674.646 21.08%
2016 -11.466.498 -202.4%
2017 -14.363.287 20.17%
2018 -31.837.205 54.89%
2019 -24.692.724 -28.93%
2020 -32.223.336 23.37%
2021 -39.187.563 17.77%
2022 -38.267.691 -2.4%
2023 -32.194.303 -18.86%
2024 -27.426.232 -17.39%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

CEL-SCI Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1986 -375
1987 -200 -87.5%
1988 -125 -60%
1989 -100 -25%
1990 -75 -33.33%
1991 -100 25%
1992 -100 0%
1993 -150 33.33%
1994 -275 45.45%
1995 -223 -23.87%
1996 -285 22.11%
1997 -218 -30.73%
1998 -141 -55.71%
1999 -129 -8.53%
2000 -110 -17.27%
2001 -123 9.84%
2002 -73 -69.44%
2003 -31 -132.26%
2004 -16 -106.67%
2005 -10 -50%
2006 -25 60%
2007 -25 -4.17%
2008 -16 -50%
2009 -77 78.95%
2010 10 860%
2011 -31 133.33%
2012 -15 -100%
2013 -8 -114.29%
2014 -12 36.36%
2015 -11 -10%
2016 -2 -400%
2017 -2 -100%
2018 -2 0%
2019 -1 0%
2020 -1 0%
2021 -1 0%
2022 -1 0%
2023 -1 0%
2024 -1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

CEL-SCI Corporation Free Cashflow
Year Free Cashflow Growth
1989 -500.000
1990 -700.000 28.57%
1991 -900.000 22.22%
1992 -1.400.000 35.71%
1993 -2.200.000 36.36%
1994 -5.000.000 56%
1995 -3.700.000 -35.14%
1996 -5.300.000 30.19%
1997 -6.200.000 14.52%
1998 -6.000.000 -3.33%
1999 -6.400.000 6.25%
2000 -8.813.050 27.38%
2001 -8.790.718 -0.25%
2002 -4.247.356 -106.97%
2003 -2.545.713 -66.84%
2004 -4.449.968 42.79%
2005 -3.223.074 -38.07%
2006 -8.766.531 63.23%
2007 -5.209.420 -68.28%
2008 -11.445.890 54.49%
2009 -7.263.692 -57.58%
2010 -13.355.342 45.61%
2011 -22.894.878 41.67%
2012 -12.323.609 -85.78%
2013 -13.681.341 9.92%
2014 -23.066.883 40.69%
2015 -23.926.864 3.59%
2016 -23.116.717 -3.5%
2017 -13.808.896 -67.4%
2018 -13.447.698 -2.69%
2019 -16.656.524 19.26%
2020 -17.971.042 7.31%
2021 -27.825.986 35.42%
2022 -18.901.584 -47.22%
2023 -23.220.823 18.6%
2024 -4.567.365 -408.41%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

CEL-SCI Corporation Operating Cashflow
Year Operating Cashflow Growth
1989 -500.000
1990 -700.000 28.57%
1991 -900.000 22.22%
1992 -1.400.000 35.71%
1993 -2.200.000 36.36%
1994 -4.000.000 45%
1995 -3.500.000 -14.29%
1996 -5.300.000 33.96%
1997 -5.900.000 10.17%
1998 -5.900.000 0%
1999 -6.300.000 6.35%
2000 -8.529.007 26.13%
2001 -8.586.384 0.67%
2002 -4.232.043 -102.89%
2003 -2.538.808 -66.69%
2004 -4.397.793 42.27%
2005 -3.069.372 -43.28%
2006 -8.675.827 64.62%
2007 -4.890.077 -77.42%
2008 -7.941.790 38.43%
2009 -6.513.309 -21.93%
2010 -12.804.207 49.13%
2011 -22.555.411 43.23%
2012 -12.190.013 -85.03%
2013 -13.548.580 10.03%
2014 -22.928.019 40.91%
2015 -23.833.333 3.8%
2016 -23.082.493 -3.25%
2017 -13.791.894 -67.36%
2018 -13.389.558 -3%
2019 -16.320.685 17.96%
2020 -15.276.161 -6.84%
2021 -18.787.016 18.69%
2022 -18.240.951 -2.99%
2023 -22.848.561 20.17%
2024 -4.543.893 -402.84%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

CEL-SCI Corporation Capital Expenditure
Year Capital Expenditure Growth
1989 0
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 1.000.000 100%
1995 200.000 -400%
1996 0 0%
1997 300.000 100%
1998 100.000 -200%
1999 100.000 0%
2000 284.043 64.79%
2001 204.334 -39.01%
2002 15.313 -1234.38%
2003 6.905 -121.77%
2004 52.175 86.77%
2005 153.702 66.05%
2006 90.704 -69.45%
2007 319.343 71.6%
2008 3.504.100 90.89%
2009 750.383 -366.97%
2010 551.135 -36.15%
2011 339.467 -62.35%
2012 133.596 -154.1%
2013 132.761 -0.63%
2014 138.864 4.39%
2015 93.531 -48.47%
2016 34.224 -173.29%
2017 17.002 -101.29%
2018 58.140 70.76%
2019 335.839 82.69%
2020 2.694.881 87.54%
2021 9.038.970 70.19%
2022 660.633 -1268.23%
2023 372.262 -77.46%
2024 23.472 -1485.98%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

CEL-SCI Corporation Equity
Year Equity Growth
1986 -100.000
1987 400.000 125%
1988 -100.000 500%
1989 -9.500.000 98.95%
1990 -10.500.000 9.52%
1991 900.000 1266.67%
1992 13.300.000 93.23%
1993 10.900.000 -22.02%
1994 6.700.000 -62.69%
1995 4.800.000 -39.58%
1996 11.600.000 58.62%
1997 5.800.000 -100%
1998 14.000.000 58.57%
1999 7.100.000 -97.18%
2000 12.961.459 45.22%
2001 4.001.193 -223.94%
2002 1.062.171 -276.7%
2003 1.225.106 13.3%
2004 5.297.829 76.88%
2005 2.105.039 -151.67%
2006 -930.601 326.2%
2007 14.670.099 106.34%
2008 10.836.035 -35.38%
2009 8.840.644 -22.57%
2010 27.854.765 68.26%
2011 9.078.824 -206.81%
2012 7.027.432 -29.19%
2013 6.700.090 -4.89%
2014 10.443.400 35.84%
2015 -5.230.243 299.67%
2016 -956.068 -447.06%
2017 -3.336.977 71.35%
2018 916 364398.8%
2019 5.133.667 99.98%
2020 19.726.674 73.98%
2021 56.534.226 65.11%
2022 32.163.207 -75.77%
2023 13.214.890 -143.39%
2024 8.473.057 -55.96%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

CEL-SCI Corporation Assets
Year Assets Growth
1986 300.000
1987 700.000 57.14%
1988 600.000 -16.67%
1989 500.000 -20%
1990 500.000 0%
1991 1.600.000 68.75%
1992 13.800.000 88.41%
1993 11.600.000 -18.97%
1994 8.100.000 -43.21%
1995 6.400.000 -26.56%
1996 11.900.000 46.22%
1997 6.300.000 -88.89%
1998 14.400.000 56.25%
1999 7.600.000 -89.47%
2000 13.808.882 44.96%
2001 4.508.920 -206.26%
2002 3.771.258 -19.56%
2003 2.915.206 -29.37%
2004 5.513.810 47.13%
2005 3.092.352 -78.3%
2006 9.653.277 67.97%
2007 20.730.802 53.44%
2008 14.683.672 -41.18%
2009 46.027.598 68.1%
2010 37.804.985 -21.75%
2011 18.625.440 -102.97%
2012 16.067.450 -15.92%
2013 10.838.572 -48.24%
2014 19.230.434 43.64%
2015 15.447.603 -24.49%
2016 11.598.247 -33.19%
2017 22.924.174 49.41%
2018 29.586.422 22.52%
2019 27.622.994 -7.11%
2020 40.536.454 31.86%
2021 75.869.965 46.57%
2022 50.523.706 -50.17%
2023 30.528.250 -65.5%
2024 24.068.320 -26.84%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

CEL-SCI Corporation Liabilities
Year Liabilities Growth
1986 400.000
1987 300.000 -33.33%
1988 700.000 57.14%
1989 500.000 -40%
1990 500.000 0%
1991 700.000 28.57%
1992 500.000 -40%
1993 700.000 28.57%
1994 1.400.000 50%
1995 1.600.000 12.5%
1996 300.000 -433.33%
1997 500.000 40%
1998 400.000 -25%
1999 500.000 20%
2000 847.423 41%
2001 507.727 -66.91%
2002 2.709.087 81.26%
2003 1.690.100 -60.29%
2004 215.981 -682.52%
2005 987.313 78.12%
2006 10.583.878 90.67%
2007 6.060.703 -74.63%
2008 3.847.637 -57.52%
2009 37.186.954 89.65%
2010 9.950.220 -273.73%
2011 9.546.616 -4.23%
2012 9.040.018 -5.6%
2013 4.138.482 -118.44%
2014 8.787.034 52.9%
2015 20.677.846 57.51%
2016 12.554.315 -64.71%
2017 26.261.151 52.19%
2018 29.585.506 11.24%
2019 22.489.327 -31.55%
2020 20.809.780 -8.07%
2021 19.335.739 -7.62%
2022 18.360.499 -5.31%
2023 17.313.360 -6.05%
2024 15.595.263 -11.02%

CEL-SCI Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.53
Price to Earning Ratio
-1.99x
Price To Sales Ratio
0x
POCF Ratio
-2.98
PFCF Ratio
-3.38
Price to Book Ratio
6.69
EV to Sales
0
EV Over EBITDA
-3.22
EV to Operating CashFlow
-4.02
EV to FreeCashFlow
-3.99
Earnings Yield
-0.5
FreeCashFlow Yield
-0.3
Market Cap
0,06 Bil.
Enterprise Value
0,08 Bil.
Graham Number
1.36
Graham NetNet
-0.26

Income Statement Metrics

Net Income per Share
-0.53
Income Quality
0.67
ROE
-2.34
Return On Assets
-1.18
Return On Capital Employed
-1.49
Net Income per EBT
1
EBT Per Ebit
1.03
Ebit per Revenue
0
Effective Tax Rate
-0.01

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.35
Free CashFlow per Share
-0.35
Capex to Operating CashFlow
-0.01
Capex to Revenue
0
Capex to Depreciation
0.02
Return on Invested Capital
-1.36
Return on Tangible Assets
-1.19
Days Sales Outstanding
0
Days Payables Outstanding
125.74
Days of Inventory on Hand
234.62
Receivables Turnover
0
Payables Turnover
2.9
Inventory Turnover
1.56
Capex per Share
0

Balance Sheet

Cash per Share
0,01
Book Value per Share
0,16
Tangible Book Value per Share
0.15
Shareholders Equity per Share
0.16
Interest Debt per Share
0.24
Debt to Equity
1.43
Debt to Assets
0.5
Net Debt to EBITDA
-0.5
Current Ratio
0.64
Tangible Asset Value
0,01 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
16171289
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.01
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
2522266.5
Debt to Market Cap
0.19

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

CEL-SCI Corporation Dividends
Year Dividends Growth
1996 0

CEL-SCI Corporation Profile

About CEL-SCI Corporation

CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC; CEL-2000 and CEL-4000 are product candidates for the treatment of rheumatoid arthritis; and LEAPS COV-19, a product candidate to treat COVID-19 coronavirus. CEL-SCI Corporation has a collaboration agreement with the University of Georgia's Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.

CEO
Mr. Geert R. Kersten Esq.
Employee
43
Address
8229 Boone Boulevard
Vienna, 22182

CEL-SCI Corporation Executives & BODs

CEL-SCI Corporation Executives & BODs
# Name Age
1 Dr. Daniel H. Zimmerman Ph.D.
Senior Vice President of Research & Cellular Immunology
70
2 Mr. Geert R. Kersten Esq.
Chief Executive & Financial Officer, Treasurer and Director
70
3 Mr. John Cipriano
Senior Vice President of Regulatory Affairs
70
4 Dr. Eyal Talor Ph.D.
Chief Scientific Officer
70
5 Ms. Patricia B. Prichep
Senior Vice President of Operations & Corporate Secretary
70

CEL-SCI Corporation Competitors